Evidence map›Paper›PMID 42064603›Full record

ReviewChemical & biomedical imaging2026

Probing Heterogeneous Catalytic Reactions via Tip-Enhanced Raman Spectroscopy: Recent Progress and Future Perspectives.

Yusheng Zhang, Yuqin Xu, Jing-Juan Xu, Li-Qing Zheng

Abstract readReview
In one paragraph

Review in Chemical & biomedical imaging, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Yusheng ZhangState Key Laboratory of Analytical Chemistry for Life Science, School of Chemistry and Chemical Engineering, Nanjing University, Nanjing 210023, People's Republic of China.
Yuqin XuState Key Laboratory of Analytical Chemistry for Life Science, School of Chemistry and Chemical Engineering, Nanjing University, Nanjing 210023, People's Republic of China.
Jing-Juan XuState Key Laboratory of Analytical Chemistry for Life Science, School of Chemistry and Chemical Engineering, Nanjing University, Nanjing 210023, People's Republic of China.ORCID https://orcid.org/0000-0001-9579-9318
Li-Qing ZhengState Key Laboratory of Analytical Chemistry for Life Science, School of Chemistry and Chemical Engineering, Nanjing University, Nanjing 210023, People's Republic of China.ORCID https://orcid.org/0000-0001-7848-6985

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Heterogeneous catalysis is pivotal to modern chemical industries, and molecular-level insights into catalytic processes are essential for developing highly efficient catalysts and advancing energy conversion technologies. Tip-enhanced Raman spectroscopy (TERS), which integrates scanning probe microscopy with plasmon-enhanced Raman spectroscopy, provides chemical and topographic information simultaneously with exceptional sensitivity and nanoscale spatial resolution. This technique is ideally suited for the nanoscale chemical characterization of solid catalysts, enabling direct structure-performance correlations. In this review, we first introduce the fundamental principles of TERS, and then highlight its key applications in probing heterogeneous catalysis, focusing on critical aspects such as active sites, molecular activation pathways, conversion efficiency, chemical selectivity, and operando studies. We conclude by discussing current challenges and potential strategies to advance TERS in heterogeneous catalysis, and by outlining future directions for the field.

Indexed as

activation pathwayactive siteschemical selectivityelectrocatalysisheterogeneous catalysisoperando studiesspatial resolutiontip-enhanced Raman spectroscopy

Identifiers

PMID42064603
PMCPMC13126366

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.